Boston Scientific (BSX) Non-Current Debt (2016 - 2025)
Boston Scientific (BSX) has disclosed Non-Current Debt for 17 consecutive years, with $11.1 billion as the latest value for Q4 2025.
- Quarterly Non-Current Debt rose 24.19% to $11.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.1 billion through Dec 2025, up 24.19% year-over-year, with the annual reading at $11.1 billion for FY2025, 24.19% up from the prior year.
- Non-Current Debt hit $11.1 billion in Q4 2025 for Boston Scientific, roughly flat from $11.1 billion in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $11.1 billion in Q4 2025 to a low of $8.4 billion in Q3 2023.
- Historically, Non-Current Debt has averaged $9.3 billion across 5 years, with a median of $8.9 billion in 2022.
- Biggest five-year swings in Non-Current Debt: decreased 6.31% in 2023 and later rose 24.19% in 2025.
- Year by year, Non-Current Debt stood at $8.8 billion in 2021, then rose by 1.26% to $8.9 billion in 2022, then fell by 3.86% to $8.6 billion in 2023, then rose by 4.63% to $9.0 billion in 2024, then rose by 24.19% to $11.1 billion in 2025.
- Business Quant data shows Non-Current Debt for BSX at $11.1 billion in Q4 2025, $11.1 billion in Q3 2025, and $11.1 billion in Q2 2025.